Arshed A Quyyumi Selected Research

C-Reactive Protein

1/2024	Factors Associated With Fatigue in Persons With Atrial Fibrillation in the Atherosclerosis Risk in Communities (ARIC) Study.
12/2023	Immune Activation Mediates the Association of Advanced Hepatic Fibrosis With Adverse Outcomes in Patients With Coronary Artery Disease.
10/2023	Soluble urokinase Plasminogen Activator Receptor (suPAR) mediates the effect of a lower education level on adverse outcomes in patients with coronary artery disease.
11/2021	Associations Between Inflammation, Cardiovascular Regenerative Capacity, and Cardiovascular Events: A Cohort Study.
1/2018	Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities.
12/2017	Association between oxidative stress and atrial fibrillation.
7/2017	An Aggregate Biomarker Risk Score Predicts High Risk of Near-Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
5/2017	Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study.
1/2017	Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.
4/2014	Effects of clopidogrel therapy on oxidative stress, inflammation, vascular function, and progenitor cells in stable coronary artery disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arshed A Quyyumi Research Topics

Disease

49	Coronary Artery Disease (Coronary Atherosclerosis) 05/2024 - 10/2002
32	Cardiovascular Diseases (Cardiovascular Disease) 06/2024 - 06/2004
20	Inflammation (Inflammations) 12/2023 - 03/2011
19	Atherosclerosis 02/2024 - 06/2003
16	Myocardial Infarction 01/2024 - 01/2006
14	Heart Failure 01/2024 - 01/2009
13	Hypertension (High Blood Pressure) 10/2022 - 02/2008
13	Ischemia 01/2020 - 10/2002
12	Myocardial Ischemia (Ischemic Heart Diseases) 11/2023 - 10/2002
8	Chronic Renal Insufficiency 01/2022 - 02/2015
5	Hyperemia 01/2023 - 10/2002
5	Peripheral Arterial Disease 01/2020 - 12/2008
5	Coronary Disease (Coronary Heart Disease) 01/2019 - 01/2005
4	Cardiomyopathies (Cardiomyopathy) 12/2023 - 05/2015
4	Infarction (Infarctions) 01/2017 - 11/2008
4	Atherosclerotic Plaque (Atheroma) 01/2016 - 10/2012
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2013 - 09/2004
3	Pathologic Constriction (Stenosis) 01/2024 - 07/2011
3	Obstructive Sleep Apnea 11/2023 - 11/2018
3	Diabetes Mellitus 01/2023 - 06/2014
3	Cognitive Dysfunction 10/2022 - 01/2020
3	COVID-19 01/2022 - 04/2020
3	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2012
3	ST Elevation Myocardial Infarction 01/2020 - 01/2013
3	Insulin Resistance 07/2017 - 01/2015
3	Hypercholesterolemia 02/2015 - 02/2008
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2023 - 12/2022
2	Apnea 11/2023 - 01/2019
2	Hypoxia (Hypoxemia) 04/2023 - 01/2012
2	Kidney Diseases (Kidney Disease) 01/2023 - 01/2020
2	Stroke (Strokes) 01/2022 - 08/2012
2	Prehypertension 01/2021 - 01/2020
2	Wounds and Injuries (Trauma) 01/2021 - 01/2020
2	Genetic Risk Score 01/2021 - 01/2016
2	Unstable Angina 12/2020 - 01/2020
2	Proteinuria 08/2017 - 05/2017
2	Vitamin D Deficiency 07/2017 - 12/2013
2	Cicatrix (Scar) 04/2017 - 11/2008
2	Obesity 01/2014 - 08/2010
2	Intermittent Claudication 12/2013 - 12/2008
2	Vascular Diseases (Vascular Disease) 08/2012 - 02/2008

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2004
17	C-Reactive ProteinIBA 01/2024 - 01/2005
12	Urokinase Plasminogen Activator ReceptorsIBA 12/2023 - 10/2014
9	LipidsIBA 05/2024 - 08/2010
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 05/2011
8	Troponin IIBA 11/2023 - 01/2018
7	cytidylyl-(3'-5')-cytidine (CpC)IBA 06/2023 - 10/2016
6	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2018
6	Cystine (L-Cystine)IBA 01/2020 - 09/2011
6	Glutathione (Reduced Glutathione)IBA 01/2016 - 03/2006
5	CalciumIBA 02/2024 - 10/2012
5	TroponinIBA 01/2024 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2003
5	Vitamin D FDA LinkGeneric 07/2017 - 07/2011
4	Lipoprotein(a)IBA 06/2024 - 08/2012
4	HDL CholesterolIBA 11/2023 - 01/2016
4	Interleukin-6 (Interleukin 6)IBA 11/2021 - 04/2011
4	5'-N-methylcarboxamideadenosineIBA 01/2021 - 01/2019
4	CXC ChemokinesIBA 08/2020 - 10/2017
4	Adenosine (Adenocard)FDA LinkGeneric 10/2016 - 11/2008
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2014 - 12/2010
3	CholesterolIBA 07/2023 - 07/2011
3	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 09/2017
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 07/2011
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2020 - 10/2017
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2020 - 11/2015
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 07/2009
3	25-hydroxyvitamin DIBA 07/2017 - 07/2011
3	Fibrin Fibrinogen Degradation ProductsIBA 07/2017 - 07/2013
3	Angiotensin IIIBA 04/2016 - 07/2011
3	endothelium-dependent hyperpolarization factor (EDHF)IBA 03/2016 - 06/2014
3	AldosteroneIBA 06/2014 - 01/2009
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2013 - 06/2003
2	ApolipoproteinsIBA 05/2024 - 07/2011
2	Phenobarbital (Luminal)FDA Link 01/2024 - 08/2012
2	salicylhydroxamic acid (SHAM)IBA 11/2023 - 11/2018
2	HDL LipoproteinsIBA 07/2023 - 06/2016
2	candesartanIBA 10/2022 - 01/2020
2	Angiotensin Receptor AntagonistsIBA 10/2022 - 09/2004
2	AngiotensinsIBA 10/2022 - 07/2011
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2022 - 11/2013
2	Lisinopril (Prinivil)FDA LinkGeneric 10/2022 - 01/2020
2	EpitopesIBA 08/2020 - 10/2017
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2018
2	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 02/2018 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 11/2008
2	Nebivolol FDA Link 03/2016 - 01/2016
2	Vasodilator Agents (Vasodilators)IBA 03/2016 - 11/2008
2	LDL CholesterolIBA 01/2016 - 01/2014
2	sapropterin (tetrahydrobiopterin)FDA Link 01/2016 - 02/2015
2	TeaIBA 02/2015 - 05/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2014 - 11/2013
2	Atorvastatin (Lipitor)FDA Link 10/2012 - 01/2012
2	Acetylcholine (Acetylcholine Chloride)FDA Link 08/2011 - 05/2011
2	Glutathione Disulfide (GSSG)FDA LinkGeneric 04/2011 - 03/2006

Therapy/Procedure

20	Therapeutics 02/2024 - 02/2008
3	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2016 - 12/2008
2	Catheters 06/2016 - 01/2013
2	Ligation 01/2015 - 07/2011